蜜拉藥品公司宣佈其新型口服****類似物Ketamir-2的臨床前研究結果積極，爲今年後期

快訊 · 06/10 20:32

Mira Pharmaceuticals Announces Positive Preclinical Study Results for Its Novel Oral Ketamine Analog, Ketamir-2, Paving Way for Ind Submission Later This Year

蜜拉藥品公司宣佈其新型口服****類似物Ketamir-2的臨床前研究結果積極，爲今年後期提交獨立審核申請鋪平了道路。